Since the first vaccine paved the way for the near-eradication of smallpox over 200 years ago, societies have looked to vaccines as a means to stop the spread of infectious diseases. Today the same concepts are being called upon for new disease threats including Ebola and Middle East respiratory syndrome (MERS), and the continued reemergence of diseases such as influenza strains that have existing but problematic vaccines.
Gregory Poland, M.D.,a founder of Mayo Clinic’s Vaccine Research Group in Rochester, Minn., says the future of vaccine development must include far more than discoveries in the laboratory. Read the rest of the article.
Find more research news on Discovery's Edge.